A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer

BACKGROUND: While the efficacy of immune checkpoint inhibitors (ICIs) is increasingly recognized in advanced gastric cancer (aGC), overall survival (OS) has not been consistently improved across the different randomized controlled trials (RCTs). This meta-analysis aimed to quantify the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: El Helali, Aya, Tao, Jun, Wong, Charlene H. L., Chan, Wendy Wing-Lok, Mok, Ka-Chun, Wu, Wing Fong, Shitara, Kohei, Mohler, Markus, Boku, Narikazu, Pang, Herbert, Lam, Ka On
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660259/
https://www.ncbi.nlm.nih.gov/pubmed/36387109
http://dx.doi.org/10.3389/fonc.2022.908026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660259/
https://www.ncbi.nlm.nih.gov/pubmed/36387109
http://dx.doi.org/10.3389/fonc.2022.908026

Ejemplares similares